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Abstract
Obesity is a worldwide pandemic causing increased morbidity/mortality 
and high cost for the society. Management of obesity requires multidisciplinary 
approaches including diet, food supplement, exercise, behavior change, drug, 
medical device, gut microbiome manipulation, and surgery. Over the past two 
decades, there has been a growing awareness of the importance of gut microbiome 
in human health and disease. Profound changes affecting the diversity and the 
abundance of gut microbiome are associated with several disorders including obe-
sity. A decrease in microbiome diversity and an increase in the ratio of Firmicutes-
to-Bacteroidetes phyla have been reported in obese subjects. The gut microbiome 
can be manipulated to change the host metabolism and manage obesity. Potential 
interventions include diet (e.g., low calories, low fat, and high fiber), prebiotics 
(e.g., inulin, lactulose, and resistant starch), probiotics (e.g., yogurt, cheese, and 
milk), synbiotics (combination of prebiotics and probiotics), bariatric surgery 
(e.g., Roux-en-Y gastric bypass), and fecal microbiota transplantation (through 
colonoscopy, esophagogastroduodenoscopy, orogastric tube, or oral capsule). A 
better understanding of the interactions between different diets and gut microbi-
ome should help the development of new guidelines for the prevention and man-
agement of obesity.
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1. Introduction
Obesity is excess body weight for a given height, defined by a body mass 
index (BMI) ≥ 30 kg/m2. In some Asian countries (e.g., Japan), the threshold to 
define obesity is 25 kg/m2. The main cause of obesity is an imbalance between 
energy intake and energy expenditure. Obesity is a worldwide pandemic asso-
ciated with increased morbidity/mortality and high cost for the society. The 
prevalence of obesity is increasing exponentially. The number of adult subjects 
with obesity is around 700 million worldwide. Near 4 million subjects die each 
year from the consequences of obesity. The annual cost of obesity is more than 
$2 trillion [1–3].
Management of obesity requires multidisciplinary approaches including diet, 
food supplement, exercise, behavior change, drug, medical device, gut microbiome 
manipulation, and surgery [1, 4–9]. The annual obesity treatment market is around 
$6 billion.
The human intestine harbors a complex and diverse microbial ecosystem 
referred to as gut microbiome [10–14]. This rich community of microorganisms 
Weight Management
2
has co-evolved in a symbiotic relationship with humans. Its diversity is 
influenced by several factors including host genetics, mode of birth, age, 
gender, pregnancy, BMI, diet, medications, and surgery [12, 15–31]. The 
understanding of the gut microbiome evolves at a rapid pace, but the practi-
cal application of this knowledge is still in its infancy. The gut microbiome 
is essential for the maintenance of human health. It is involved in protection 
against pathogens and regulation of immune system and metabolism [32]. 
Profound changes affecting the diversity and the abundance of gut microbiome 
(dysbiosis) are associated with several disorders including obesity [33]. The 
prevention and management of obesity may benefit from manipulation of gut 
microbiome.
2. Gut microbiome description and composition
Gut microbiome is a complex community of microorganisms living in the 
digestive tract, mainly in the colon (Figure 1). Variable pH and oxygen concentra-
tion affect the abundance of gut microbiome across the gastrointestinal tract. Gut 
microbiome represents up to 60% of the dry mass of feces (biomass around 1.5 kg), 
has more cells than host somatic cells and at least 100 times more genes than human 
genome [10–14].
Gut microbiome is established within the few first years of life and contains up 
to 100 trillion microbes, mainly bacteria (more than 1,000 species) but also fungi, 
protozoa, archaea, and viruses. The taxonomic ranking of gut microbiome includes 
species, genera, families, orders, classes, and phyla. Most of the species belong to 
Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria, and Verrucomicrobia 
phyla. The predominant phyla (90%) are Firmicutes (e.g., Ruminococcus and 
Lactobacillus genera) and Bacteroidetes (e.g., Bacteroides and Prevotella genera). 
Three enterotypes with functional differences have been defined based on variation 
in the level of genera: Enterotype 1 (Bacteroides), Enterotype 2 (Prevotella), and 
Enterotype 3 (Ruminococcus).
Figure 1. 
Gut microbiome is mainly located in the colon (Picture downloaded from the internet).
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3. Gut microbiome projects
There are two major gut microbiome projects: European Megagenomics of the 
Human Intestinal Tract and US Human Microbiome Project [11]. For gut micro-
biome studies, multiple fecal collections of the same subject are recommended. 
The assessments are DNA-based methods (16S rDNA sequencing, whole genome 
shotgun sequencing) (Figure 2) [32, 34, 35]. The challenges in the assessments of 
gut microbiome are due to the diversity and the inter/intra-individual variability 
caused by different factors such as age and diet.
4. Gut microbiome metabolism
4.1 Nutrition sources
The sources for nutrition of gut microbiome are ingested dietary components (car-
bohydrate, protein, lipid) and host-derived components (shed epithelial cells, mucus).
4.2 Metabolites
Several metabolites are produced by gut microbiome. They include short-chain 
fatty acids (following carbohydrate fermentation), phenolic substances (following 
protein fermentation), and vitamins (vitamin B, vitamin K).
5. Gut microbiome changes
Gut microbiome is diverse, varies between individuals, and can fluctuate over 
time. Western gut microbiome has less species than non-Western gut microbiome.
In addition to several pathological conditions that can alter gut microbiome 
composition, multiple factors are responsible for the changes in gut microbiome 
(Figure 3) [12, 15–31].
Figure 2. 
Assessment of gut microbiome (Picture downloaded from the internet).
Weight Management
4
5.1 Host genetics
There are possible relations between host genetic profile and gut microbiome 
composition, but additional studies are needed for a better understanding of these 
relations [15].
5.2 Mode of birth
Mode of birth has an important influence on gut microbiome composition 
[12, 16]. With vaginal delivery, infants are colonized by maternal vaginal bacteria 
(dominated by Lactobacillus and Prevotella genera) while following C-section deliv-
ery, infants are colonized by maternal skin bacteria (dominated by Staphylococcus, 
Corynebacterium, and Propionibacterium genera).
5.3 Age
Age is associated with important changes in gut microbiome [12, 17]. The 
changes occur mainly before 20 and after 70 years. The diet plays a significant role. 
In preterm infants, there is a predominance of Proteobacteria phylum. There are 
marked changes in infants. The choice of diet after birth (breast milk or formula 
milk) affects the colonization process in the newborn. With age, the introduction 
of solid food from 2 years and the production of sex hormones from puberty (to 
menopause in females) bring additional richness and complexity to gut micro-
biome. There is a relative stability of gut microbiome between 20 and 70 years 
(predominance of Firmicutes phylum). In elderly subjects, Bacteroidetes phylum is 
predominant.
Figure 3. 
Multiple factors can impact gut microbiome (Picture downloaded from the Internet).
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5.4 Gender
Gender specificity of gut microbiome appears at puberty with the production 
of sex hormones [12, 18]. There is a lower abundance of Bacteroidetes phylum in 
women (role of estrogen).
5.5 Pregnancy
Elevated levels of estrogen and progesterone observed during pregnancy have 
important impact on gut microbiome [12, 16, 19]. The changes are characterized 
by a decrease in richness of gut microbiome, a higher abundance of Proteobacteria 
and Actinobacteria phyla, a decrease in Faecalibacterium genus, and an increase in 
Firmicutes-to-Bacteroidetes phyla ratio.
5.6 BMI
BMI is associated with gut microbiome composition particularly in women 
[18]. Bacteroidetes phylum is less abundant in subjects with high BMI. The role of 
estrogen has been proposed.
5.7 Diet
Diet has an important influence on gut microbiome composition [20–25]. 
However, there is a high interindividual variability. A diet high in fat (≥ 55% of total 
macronutrients) is associated with increased Firmicutes and Proteobacteria phyla 
and decreased Bacteroidetes phylum while a diet rich in fiber (≥ 30 g/day) has the 
opposite effect. The changes in gut microbiome (composition and functionality) 
induced by diet can be observed as early as 2 days. However, major changes in gut 
microbiome require long-term change in dietary habits.
Important differences in gut microbiome have been reported in children 
between Europe and rural African village of Burkina Faso (polysaccharide-rich 
diet) with Firmicutes-to-Bacteroidetes phyla ratios of 2.8 and 0.5, respectively [26].
Diet may also contribute to the seasonal variations of gut microbiome likely due 
to different availability of fresh produce containing complex carbohydrates [27].
5.8 Medication
Several medications (e.g., antibiotics, nonsteroidal anti-inflammatory drugs, 
proton pump inhibitors, and metformin) affect gut microbiome [28–30]. The use of 
antibiotics is associated with increased Firmicutes phylum, with higher sensitivity 
in infants.
The impact of prebiotics and probiotics on gut microbiome is presented in 
Section 8.
5.9 Surgery
Since colon is the main reservoir of gut microbiome, surgical removal of colon 
may affect gut microbiome [31]. Indeed, right hemicolectomy for colorectal cancer 
has been reported to be associated with a decrease in diversity and richness of gut 
microbiome.
The impact of bariatric surgery on gut microbiome is presented in Section 8.
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6. Gut microbiome functions
The gut microbiome is involved in multiple physiological functions (Table 1) 
[32, 36–41].
6.1 Protection against pathogens
Gut microbiome can protect against pathogens by killing or inhibiting unwanted 
organisms (e.g., Clostridium difficile genera) that are competing for nutrients.
6.2 Regulation of immune system
Gut microbiome regulates immune system by influencing the production of 
cytokines and antibodies.
6.3 Regulation of metabolism
Gut microbiome is involved in several metabolic processes. These processes 
include regulation of energy homeostasis and body weight, production of short-
chain fatty acids (following fermentation of nondigestible fibers) and vitamins 
(vitamins B, vitamin K) [32, 36], glycemic control [37, 38], interaction with incre-
tins [39], and metabolism of lipids [40] and bone [41].
7. Gut microbiome in diseases
Dysbiosis is observed in several medical conditions including obesity, malnutri-
tion, type 2 diabetes, inflammatory bowel diseases, neurological disorders, and 
cancer [33, 42–48]. The dysbiosis can be the cause and/or the consequence of these 
diseases.
Gut microbiome influences drug pharmacokinetics and bioavailability, and thus, 
affects the efficacy and safety of several drugs used to treat diseases [49].
8. Gut microbiome and obesity
8.1 Gut microbiome composition in obesity
Although there are some conflicting data, most studies have reported that in 
obesity, there is a lower gut microbiome diversity, a higher abundance of Firmicutes 
Function of gut 
microbiome
Mechanism and target
Protection Killing or inhibiting unwanted organisms competing for nutrients
Immune system Influencing production of cytokines and antibodies
Metabolism Regulating energy homeostasis, producing short-chain fatty acids and vitamins, 
impacting glycemic control, interacting with incretins, regulating metabolism of 
lipids and bone
Table 1. 
Physiological functions of gut microbiome.
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phylum, a lower abundance of Bacteroidetes phylum, and a higher Firmicutes-
to-Bacteroidetes phyla ratio [33, 42–45]. There is also a higher abundance of 
Lactobacillus (genus belonging to Firmicutes phylum).
According to most studies, the low-grade inflammation stimulated by lipopoly-
saccharide production is the prime mechanism by which gut microbiome induces 
obesity [50].
8.2 Gut microbiome in obesity management
Gut microbiome can be manipulated for the purpose of obesity management 
using different tools (Table 2) [20, 21, 50–60].
8.2.1 Diet
Diet is an important factor for the manipulation of gut microbiome and manage-
ment of obesity. The amount of daily caloric intake and the content of food signifi-
cantly affect gut microbiome but with high interindividual variability [20, 21, 51]. 
A diet that is low in calories, low in fat (< 20% of total macronutrients), and high in 
fiber (≥ 30 g/day) has a favorable effect on gut microbiome (increase in richness, 
decrease in Firmicutes-to-Bacteroidetes phyla ratio) and weight control (weight loss).
8.2.2 Prebiotics
Prebiotics are chemicals (nondigestible food ingredients) inducing growth and/
or activity of bacteria [50, 52]. Prebiotics must be able to resist gastric acidity, resist 
enzymatic hydrolysis, resist absorption in the upper gastrointestinal tract, and be 
fermentable by the gut microbiome. Examples are inulin, lactulose, and resistant 
starch. Prebiotics can be found in many foods (e.g., leek, asparagus, onion, and 
soybean).
By modulating gut microbiome and lowering the production of lipopolysac-
charide, prebiotics have the potential to manage obesity. In a double-blind, 
placebo-controlled clinical study, administration of oligofructose-enriched inulin 
(8 g/day) to overweight/obese children for 16 weeks caused a significant increase 
in Bifidobacterium (genus belonging to Actinobacteria phylum) and significantly 
slowed the body weight gain compared with placebo [53].
8.2.3 Probiotics
Probiotics are nonpathogenic living microorganisms with direct or indirect 
effect on gut microbiome [50, 54, 55]. Products containing probiotics should be 
Tool for gut microbiome manipulation Description
Diet Low calories, low fat, high fiber
Prebiotics Inulin, lactulose, resistant starch
Probiotics Yogurt, cheese, milk
Synbiotics Combination of prebiotics and probiotics
Bariatric surgery Roux-en-Y gastric bypass
Fecal microbiota transplantation Addition of healthy stool
Table 2. 
Different tools used for gut microbiome manipulation in obesity management.
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tested for safety risks before marketing. Probiotics can be found in several foods 
(e.g., yogurt, cheese, and milk).
Probiotics can manage obesity by reducing the production of lipopolysaccharide 
through an impact on gut microbiome. In a double-blind, placebo-controlled clini-
cal study, administration of fermented milk containing Lactobacillus gasseri species 
(LG2055) to overweight/obese adults for 12 weeks caused a significant decrease in 
body weight [56].
8.2.4 Synbiotics
Synbiotics are combination of prebiotics and probiotics. They have the potential 
to induce more effects on gut microbiome and body weight than prebiotics or 
probiotics alone.
8.2.5 Bariatric surgery
Bariatric surgery can modify gut microbiome and further affect body weight 
[57, 58]. The mechanisms include reduced caloric intake, reduced gastric emptying, 
and alterations in gastric acid production and bile acids.
After Roux-en-Y gastric bypass surgery in obese subjects, there is a decrease in 
Firmicutes-to-Bacteroidetes phyla ratio and an increase in Proteobacteria phylum 
[57, 58].
8.2.6 Fecal microbiota transplantation
Fecal microbiota transplantation, which consists of transfer of feces from a 
healthy donor to a recipient, is an exciting therapy with important potential. It can 
modify gut microbiome for the purpose of obesity management [59, 60]. The addition 
of healthy stool can be done through colonoscopy, orogastric tube, esophagogastro-
duodenoscopy, or oral capsule. It is important to carefully select and screen the donor 
to avoid risk of infection, aggravation of obesity, or other complications [61, 62].
Available clinical data are very preliminary and limited. Several studies are 
ongoing. There is no regulatory guidance for the use of fecal microbiota transplan-
tation in the management of obesity.
8.2.7 Cost of gut microbiome manipulation
Cost of gut microbiome manipulation in obesity management is reported in 
Table 3.
Tool for gut microbiome manipulation Average cost (range)
Diet Cost of food
Prebiotics < $100/month
Probiotics < $100/month
Synbiotics < $100/month
Bariatric surgery (Roux-en-Y gastric bypass) $23,000 ($20,000–$30,000)
Fecal microbiota transplantation $1,800 ($1,600–$2,000) + cost of administration/dose
Table 3. 
Cost of different tools used for gut microbiome manipulation in obesity management in the USA.
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8.3 Gut microbiome after weight loss
After successful weight loss, there is a decrease in Firmicutes phylum, an 
increase in Bacteroidetes phylum, and a decrease of Firmicutes-to-Bacteroidetes 
phyla ratio [45, 51, 57, 58].
9. Clinical study design to assess gut microbiome in obesity
Well-designed clinical studies are urgently needed to better understand the 
interactions between obesity/obesity treatment and gut microbiome.
Several factors affect the quality of weight-loss studies aimed to assess gut 
microbiome. A well-calculated sample size allowing subgroup analysis is a key 
factor. Relevant stratification factors (e.g., race, age, gender, BMI, diet, and medica-
tions) at randomization will make the study more informative. Any underestima-
tion of these stratification factors, as it has been the case in several clinical studies, 
especially in relation to diet and medications, may lead to misleading and conflict-
ing results. The duration of the clinical studies has to be sufficient to allow both 
short-term and long-term/follow-up assessments. Adequate adjustments should be 
made during the statistical analysis.
10. Ideal gut microbiome
An ideal gut microbiome should have high diversity. At the level of phyla, the 
ideal gut microbiome should have low Firmicutes phylum and high Bacteroidetes 
phylum with a Firmicutes-to-Bacteroidetes phyla ratio < 1.0. At the level of genera, 
the ideal gut microbiome should be rich in Prevotella genus.
The recommended diet to reach the above objectives is a diet adequate in calories 
(adjusted to the activity), low in fat (< 20% of total macronutrients), and rich in 
fiber (≥ 30 g/day).
11. Conclusions
Gut microbiome influences normal physiology and susceptibility to diseases. 
Profound changes affecting the diversity and the abundance of gut microbiome 
are associated with obesity. A decrease in microbiome diversity and an increase 
in the ratio of Firmicutes-to-Bacteroidetes phyla have been reported in obese 
subjects.
Gut microbiome can be manipulated to change the host metabolism and man-
age obesity. Potential interventions include diet, prebiotics, probiotics, synbiotics, 
bariatric surgery, and fecal microbiota transplantation.
A better understanding of the interactions between different diets and gut 
microbiome should help the development of new guidelines for feeding humans to 
prevent or manage obesity.
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